BE Health Ventures
Overview
BE Health Ventures is a Taiwan-based hospital-backed venture capital firm and accelerator focused on early-stage MedTech and HealthTech startups.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Health2Sync | Mar 2025 | Series C | Co-investor |
| Dentall | Jan 2022 | Seed | Co-investor |
| Meticuly | Nov 2021 | Series B | Co-investor |
| Syncell | Jul 2025 | Series A | Co-investor |
| Homexin | Aug 2022 | Accelerator | Co-investor |
For institutional investors. Book with your work email.
Key People
Matthew Lee
Co-Founder, CEO
Andrew Chou
Venture Partner & Startup Mentor
John Kojiro Moriwaka
Venture Partner, Mentor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BE Health Ventures based?
BE Health Ventures is headquartered in Taipei City, Taiwan.
When was BE Health Ventures founded?
BE Health Ventures was founded in 2018.
How many portfolio companies does BE Health Ventures have?
BE Health Ventures has 6 portfolio companies in Caplight's dataset.
What are some companies in BE Health Ventures's portfolio?
Portfolio companies visible on Caplight include Health2Sync, Dentall, Meticuly, Syncell, Homexin.
What was BE Health Ventures's most recent investment shown here?
BE Health Ventures's most recent investment in this portfolio sample was in Syncell in 2025.
What sectors does BE Health Ventures focus on?
BE Health Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, Enterprise Software, Frontier & Industrial Tech.
What company stages does BE Health Ventures focus on?
BE Health Ventures typically invests at the Early stage.